Publicaciones en colaboración con investigadores/as de Fondazione IRCCS Istituto Nazionale dei Tumori (8)

2021

  1. The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei after Cytoreductive Surgery

    JAMA Surgery, Vol. 156, Núm. 3

2014

  1. Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei

    British Journal of Surgery, Vol. 101, Núm. 13, pp. 1758-1765

  2. The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis

    Annals of Surgical Oncology, Vol. 21, Núm. 13, pp. 4195-4201

  3. The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery

    Journal of Surgical Oncology, Vol. 110, Núm. 7, pp. 779-785

2012

  1. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

    Journal of Clinical Oncology, Vol. 30, Núm. 20, pp. 2449-2456

2011

  1. Erratum: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: A consensus statement (Annals of Surgical Oncology 14 (128-133)DOI: 10.1245/s10434-006-9185-7)

    Annals of Surgical Oncology

2008

  1. The intraoperative staging systems in the management of peritoneal surface malignancy

    Journal of Surgical Oncology

2007

  1. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: A consensus statement

    Annals of Surgical Oncology, Vol. 14, Núm. 1, pp. 128-133